119-HRES-1090 Journalist Public Summary
119 · HRES 1090 Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month".
A bipartisan, nonbinding House resolution to mark February 2026 as Low Vision and Vision Impairment Awareness Month; it spotlights the scale and costs of vision loss, urges HHS to boost public information, surveillance, research, and stakeholder convenings, and promotes access to eye health information—without changing law or spending on its own.
Public Summary — H. Res. 1090 (119th Congress)
Headline Summary: The House is considering a symbolic, bipartisan resolution to recognize February 2026 as Low Vision and Vision Impairment Awareness Month and to encourage stronger public information, data tracking, and research on eye health.
What It Does: This simple resolution does not change law or create new programs. It expresses support for raising awareness of vision loss; highlights the personal, economic, and public‑health impacts; and urges the Department of Health and Human Services to share clearer information on common eye diseases, continue national surveillance of vision loss, support additional research, and convene patients, caregivers, clinicians, and researchers to develop practical, evidence‑based tools. It also promotes making information about access to eye care and assistive devices easier to find for parents, schools, and communities.
- Who’s For It: Sponsored by Rep. Marc Veasey (D‑TX) with lead cosponsor Rep. Gus Bilirakis (R‑FL), signaling bipartisan backing. Support is likely from eye‑health and patient‑advocacy groups that emphasize early detection, prevention, and the high costs of untreated vision problems.
- What supporters say: Recognizing an awareness month can drive screenings and earlier treatment; better data (like the Vision and Eye Health Surveillance System) and research can reduce preventable vision loss and lower long‑run costs for families and public programs.
- Who’s Against It: No formal opposition is noted at introduction. Potential skeptics may view it as largely symbolic, prefer that Congress tackle coverage gaps (e.g., routine vision benefits under Medicare) through separate legislation, or question implicit calls for increased research or program activity absent specified funding.
What’s Next: As a House simple resolution, it applies only to the House. It was introduced and referred to the House Committee on Energy and Commerce on February 26, 2026. If the committee and then the full House approve it, the resolution is considered agreed to; it does not go to the Senate or the President.
Discussion